ShortCut™
Coronary obstruction risk in valve‑in‑valve TAVR
Commercial (cleared)Active
Key Facts
Indication
Coronary obstruction risk in valve‑in‑valve TAVR
Phase
Commercial (cleared)
Status
Active
Company
About Pi-Cardia
Pi-Cardia creates non‑implant catheter solutions to modify heart valve leaflets for safer transcatheter valve procedures.
View full company profile